Xconomy National

by in

Entry	Author	Date	Location
Genzyme MS Drug Significantly Reduces Relapse, Disability in Late-Stage Trial	Arlene Weintraub	11/14/11	Boston
Acorda Stock Halted as Shares Skyrocket on Patent Speculation	Arlene Weintraub	04/14/11	New York
Biogen Gets Int’l Rights to Acorda’s MS Drug	Roxanne Palmer	07/01/09	Boston
Biogen Reports 10th PML Case in Tysabri Patient	Roxanne Palmer	06/29/09	Boston
FDA Allows High-Yield Tysabri Production	Ryan McBride	04/16/09	Boston
Genzyme Rises on Promising Campath Data and (or) Takeover Speculation	Robert Buderi	10/15/07	Boston
Page 1 of 1